These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39178958)

  • 1. Unveiling the link between glymphatic function and cortical microstructures in post-traumatic stress disorder.
    Shao Z; Gao X; Cen S; ; Tang X; Gong J; Ding W
    J Affect Disord; 2024 Nov; 365():341-350. PubMed ID: 39178958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
    Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT
    Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
    Kim M; Song YS; Han K; Bae YJ; Han JW; Kim KW
    J Alzheimers Dis; 2024; 99(1):279-290. PubMed ID: 38669532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function.
    Zhang X; Wang Y; Jiao B; Wang Z; Shi J; Zhang Y; Bai X; Li Z; Li S; Bai R; Sui B
    Eur Radiol; 2024 Feb; 34(2):1314-1323. PubMed ID: 37610441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.
    Ota M; Sato N; Nakaya M; Shigemoto Y; Kimura Y; Chiba E; Yokoi Y; Tsukamoto T; Matsuda H
    J Alzheimers Dis; 2022; 90(1):295-303. PubMed ID: 36120782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/MRI multimodality imaging to evaluate changes in glymphatic system function and biomarkers of Alzheimer's disease.
    Okazawa H; Nogami M; Ishida S; Makino A; Mori T; Kiyono Y; Ikawa M
    Sci Rep; 2024 May; 14(1):12310. PubMed ID: 38811627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial and temporal patterns of cortical mean diffusivity in Alzheimer's disease and suspected non-Alzheimer's disease pathophysiology.
    Sun P; He Z; Li A; Yang J; Zhu Y; Cai Y; Ma T; Ma S; Guo T;
    Alzheimers Dement; 2024 Oct; 20(10):7048-7061. PubMed ID: 39132849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer's disease continuum participants.
    Hong H; Hong L; Luo X; Zeng Q; Li K; Wang S; Jiaerken Y; Zhang R; Yu X; Zhang Y; Lei C; Liu Z; Chen Y; Huang P; Zhang M;
    Alzheimers Res Ther; 2024 Feb; 16(1):43. PubMed ID: 38378607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
    Kamagata K; Andica C; Takabayashi K; Saito Y; Taoka T; Nozaki H; Kikuta J; Fujita S; Hagiwara A; Kamiya K; Wada A; Akashi T; Sano K; Nishizawa M; Hori M; Naganawa S; Aoki S;
    Neurology; 2022 Dec; 99(24):e2648-e2660. PubMed ID: 36123122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space (DTI-ALPS) in dementia patients.
    Liang T; Chang F; Huang Z; Peng D; Zhou X; Liu W
    Br J Radiol; 2023 Jun; 96(1146):20220315. PubMed ID: 37066824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A "glympse" into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin-4 for the assessment of glymphatic system in Alzheimer's disease and other dementias.
    Sacchi L; D'Agata F; Campisi C; Arcaro M; Carandini T; Örzsik B; Dal Maschio VP; Fenoglio C; Pietroboni AM; Ghezzi L; Serpente M; Pintus M; Conte G; Triulzi F; Lopiano L; Galimberti D; Cercignani M; Bozzali M; Arighi A
    Hum Brain Mapp; 2024 Aug; 45(12):e26805. PubMed ID: 39185685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal assessment of brain fluid clearance is associated with amyloid-beta deposition in humans.
    Zhou L; Butler TA; Wang XH; Xi K; Tanzi EB; Glodzik L; Chiang GC; de Leon MJ; Li Y
    J Neuroradiol; 2024 Jun; 51(4):101164. PubMed ID: 37907155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting-state fMRI network efficiency as a mediator in the relationship between the glymphatic system and cognitive function in obstructive sleep apnea hypopnea syndrome: Insights from a DTI-ALPS investigation.
    Xiong Z; Bai M; Wang Z; Wang R; Tian C; Wang L; Nie L; Zeng X
    Sleep Med; 2024 Jul; 119():250-257. PubMed ID: 38704873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of MRI-Derived Glymphatic System Impairment With Global White Matter Damage and Cognitive Impairment in Mild Traumatic Brain Injury: A DTI-ALPS Study.
    Yang DX; Sun Z; Yu MM; Zou QQ; Li PY; Zhang JK; Wu X; Li YH; Wang ML
    J Magn Reson Imaging; 2024 Feb; 59(2):639-647. PubMed ID: 37276070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases.
    Taoka T; Masutani Y; Kawai H; Nakane T; Matsuoka K; Yasuno F; Kishimoto T; Naganawa S
    Jpn J Radiol; 2017 Apr; 35(4):172-178. PubMed ID: 28197821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the DTI-ALPS Parameter Along the Perivascular Space in Older Adults at Risk of Dementia.
    Steward CE; Venkatraman VK; Lui E; Malpas CB; Ellis KA; Cyarto EV; Vivash L; O'Brien TJ; Velakoulis D; Ames D; Masters CL; Lautenschlager NT; Bammer R; Desmond PM
    J Neuroimaging; 2021 May; 31(3):569-578. PubMed ID: 33556226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glymphatic function assessment with diffusion tensor imaging along the perivascular space in patients with major depressive disorder and its relation to cerebral white-matter alteration.
    Yang C; Tian S; Du W; Liu M; Hu R; Gao B; Pan T; Song Q; Liu T; Wang W; Zhang H; Miao Y
    Quant Imaging Med Surg; 2024 Sep; 14(9):6397-6412. PubMed ID: 39281139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter reserve determines glymphatic system function in young-onset Alzheimer's disease: Evidenced by DTI-ALPS and compared with age-matched controls.
    Chang HI; Huang CW; Hsu SW; Huang SH; Lin KJ; Ho TY; Ma MC; Hsiao WC; Chang CC
    Psychiatry Clin Neurosci; 2023 Jul; 77(7):401-409. PubMed ID: 37097074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging findings related to glymphatic system alterations in older adults with metabolic syndrome.
    Andica C; Kamagata K; Takabayashi K; Kikuta J; Kaga H; Someya Y; Tamura Y; Kawamori R; Watada H; Taoka T; Naganawa S; Aoki S
    Neurobiol Dis; 2023 Feb; 177():105990. PubMed ID: 36621631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.